Zimmer Biomet
818 hedge funds and large institutions have $20.6B invested in Zimmer Biomet in 2017 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 291 increasing their positions, 274 reducing their positions, and 57 closing their positions.
171% more call options, than puts
Call options by funds: $159M | Put options by funds: $58.8M
16% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 57
6% more repeat investments, than reductions
Existing positions increased: 291 | Existing positions reduced: 274
0.04% less ownership
Funds ownership: 89.54% → 89.5% (-0.04%)
0% less funds holding
Funds holding: 819 → 818 (-1)
9% less capital invested
Capital invested by funds: $22.5B → $20.6B (-$1.94B)
35% less funds holding in top 10
Funds holding in top 10: 23 → 15 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$283M |
| 2 |
JP
Jana Partners
New York
|
+$174M |
| 3 |
JP Morgan Chase
New York
|
+$171M |
| 4 |
HM
HealthCor Management
New York
|
+$141M |
| 5 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$134M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ninety One (UK)
London,
United Kingdom
|
-$188M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$172M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$161M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$134M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$111M |
ZBH Hedge Fund Activity: Q3 2017 in Review
818 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2017, worth a combined $20.6B — down 8.6% from $22.5B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new ZBH positions and 57 closed out — a net gain of 9 holders — while 291 added to existing stakes and 274 trimmed.
The largest buyer was Glenview Capital Management, adding an estimated $283M. The largest seller was Ninety One (UK), cutting an estimated $188M.
- 818 institutional investors held Zimmer Biomet (ZBH) as of Q3 2017, down from 819 in Q2 2017.
- Funds reported $20.6B of Zimmer Biomet stock for Q3 2017, down 8.6% quarter-over-quarter.
- 66 funds opened new Zimmer Biomet positions in Q3 2017 and 57 closed out, a net change of +9 holders.
- The largest Zimmer Biomet buyer in Q3 2017 was Glenview Capital Management, an estimated $283M added.
- The largest Zimmer Biomet seller in Q3 2017 was Ninety One (UK), an estimated $188M sold.
Based on aggregated 13F filings for Q3 2017.